The expression of NR2F2‐AS1 was more up‐regulated in patients with advanced TNM stage or positive lymphatic metastasis, demonstrating that NR2F2‐AS1 may be involved in the progression of NSCLC. Here, NR2F2 is linked to non-small cell lung carcinoma.